Therapy

Two therapies receive orphan drug status – Healio

The FDA granted orphan drug designation to two therapies in development for hematologic malignancies.

  • Umbralisib (TG Therapeutics) received orphan drug designation for the treatment of follicular lymphoma.
  • Umbralisib — a dual inhibitor of the PI3 kinase-delta and CK1-epsilon —…

    source website